These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 36047424)
1. Bladder cancer diagnosis with a four-miRNA panel in serum. Li X; Chen W; Li R; Chen X; Huang G; Lu C; Wen Z; Peng X; Liu K; Zhang C; Li H; Hu Y; Zhao Z; Tao L; Lai Y Future Oncol; 2022 Sep; 18(29):3311-3322. PubMed ID: 36047424 [TBL] [Abstract][Full Text] [Related]
2. A Panel of Three Serum MicroRNAs as a Potential Diagnostic Biomarker for Urothelial Carcinoma. Li H; Huang G; Lai Y; Ni L; Lai Y Oncol Res Treat; 2022; 45(6):344-352. PubMed ID: 35231919 [TBL] [Abstract][Full Text] [Related]
3. Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study. Lu C; Lin S; Wen Z; Sun C; Ge Z; Chen W; Li Y; Zhang P; Wu Y; Wang W; Chen S; Zhou H; Li X; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Wu X; Lai Y Biomarkers; 2024 Jul; 29(5):276-284. PubMed ID: 38767408 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer. Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929 [TBL] [Abstract][Full Text] [Related]
5. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer. Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847 [TBL] [Abstract][Full Text] [Related]
6. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma. Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286 [TBL] [Abstract][Full Text] [Related]
7. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma. He T; Lu C; Gong W; Ge Z; Li R; Li X; Sun C; Li W; Long Q; Liu Q; Lai Y Front Biosci (Landmark Ed); 2024 May; 29(5):186. PubMed ID: 38812297 [TBL] [Abstract][Full Text] [Related]
8. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test. Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801 [TBL] [Abstract][Full Text] [Related]
9. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder. Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881 [TBL] [Abstract][Full Text] [Related]
10. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
11. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
12. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985 [TBL] [Abstract][Full Text] [Related]
13. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
14. Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine. Lin JT; Tsai KW Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924142 [TBL] [Abstract][Full Text] [Related]
15. A serum miRNAs signature for early diagnosis of bladder cancer. Yu Z; Lu C; Lai Y Ann Med; 2023 Dec; 55(1):736-745. PubMed ID: 36856518 [TBL] [Abstract][Full Text] [Related]
16. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer. Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907 [TBL] [Abstract][Full Text] [Related]
17. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239 [TBL] [Abstract][Full Text] [Related]
18. A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis. Li R; Chen X; Li X; Huang G; Lu C; Wen Z; Chen Z; Lai Y Am J Transl Res; 2022; 14(7):4606-4616. PubMed ID: 35958461 [TBL] [Abstract][Full Text] [Related]
19. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer. Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174 [TBL] [Abstract][Full Text] [Related]
20. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer. Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]